Diagnostic Value of Sural Nerve Biopsy: Retrospective Analysis of Clinical Cases From 1981 to 2017

Valeria Prada, Sara Massucco, Consuelo Venturi, Alessandro Geroldi, Emilia Bellone, Paola Mandich, Michele Minuto, Emanuela Varaldo, Giovanni Mancardi, Marina Grandis, Angelo Schenone

Research output: Contribution to journalArticle

Abstract

Nerve biopsy represents the conclusive step in the diagnostic work-up of peripheral neuropathies, and its diagnostic yield is still debated. The aim of this study is to consider the impact of nerve biopsy on reaching a useful diagnosis in different peripheral neuropathies and its changing over time. We retrospectively analyzed 1,179 sural nerve biopsies performed in the period 1981–2017 at Neurological Clinic of Policlinico San Martino (Genoa). We relied on medical records and collected both clinical and pathological data in a database. Biopsy provided univocal diagnoses in 53% of cases (with an increase over time), multiple diagnostic options in 14%, while diagnosis was undetermined in 33% (undetermined reports decreased during the years). In 57% of patients, the pre-biopsy suspicion was confirmed, while in 43% sural biopsy modified the clinical diagnosis. The highest yield was in axonal neuropathies (29% undetermined reports vs. 40% in demyelinating and 48% in mixed neuropathies). In 68% of patients with vasculitic neuropathy, this etiology was already suspected, whereas in 32% nerve biopsy modified the clinical diagnosis. During the years, the number of annually performed biopsies decreased significantly (p = 0.007), with an increase in the mean age of patients (p < 0.0001). The percentage of hereditary neuropathies had a significant decrease (p = 0.016), while the rate of vasculitic and chronic inflammatory neuropathies increased (p < 0.0001). This is the largest Italian study addressing the yield of sural nerve biopsy. During the years, we observed a progressive refinement of the indication of this procedure, which confirms its utility for interstitial neuropathies, particularly if non-systemic vasculitic neuropathy is suspected.

Original languageEnglish
Article number1218
JournalFrontiers in Neurology
Volume10
DOIs
Publication statusPublished - Nov 22 2019

Fingerprint

Sural Nerve
Biopsy
Peripheral Nervous System Diseases
Medical Records
Databases

Keywords

  • amyloidotic neuropathy
  • axonal neuropathies
  • demyelinating neuropathies
  • neuropathy
  • sural nerve biopsy
  • vasculitic neuropathy

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Diagnostic Value of Sural Nerve Biopsy : Retrospective Analysis of Clinical Cases From 1981 to 2017. / Prada, Valeria; Massucco, Sara; Venturi, Consuelo; Geroldi, Alessandro; Bellone, Emilia; Mandich, Paola; Minuto, Michele; Varaldo, Emanuela; Mancardi, Giovanni; Grandis, Marina; Schenone, Angelo.

In: Frontiers in Neurology, Vol. 10, 1218, 22.11.2019.

Research output: Contribution to journalArticle

@article{3e8171038fa849ccb02fa90b01e5adfa,
title = "Diagnostic Value of Sural Nerve Biopsy: Retrospective Analysis of Clinical Cases From 1981 to 2017",
abstract = "Nerve biopsy represents the conclusive step in the diagnostic work-up of peripheral neuropathies, and its diagnostic yield is still debated. The aim of this study is to consider the impact of nerve biopsy on reaching a useful diagnosis in different peripheral neuropathies and its changing over time. We retrospectively analyzed 1,179 sural nerve biopsies performed in the period 1981–2017 at Neurological Clinic of Policlinico San Martino (Genoa). We relied on medical records and collected both clinical and pathological data in a database. Biopsy provided univocal diagnoses in 53{\%} of cases (with an increase over time), multiple diagnostic options in 14{\%}, while diagnosis was undetermined in 33{\%} (undetermined reports decreased during the years). In 57{\%} of patients, the pre-biopsy suspicion was confirmed, while in 43{\%} sural biopsy modified the clinical diagnosis. The highest yield was in axonal neuropathies (29{\%} undetermined reports vs. 40{\%} in demyelinating and 48{\%} in mixed neuropathies). In 68{\%} of patients with vasculitic neuropathy, this etiology was already suspected, whereas in 32{\%} nerve biopsy modified the clinical diagnosis. During the years, the number of annually performed biopsies decreased significantly (p = 0.007), with an increase in the mean age of patients (p < 0.0001). The percentage of hereditary neuropathies had a significant decrease (p = 0.016), while the rate of vasculitic and chronic inflammatory neuropathies increased (p < 0.0001). This is the largest Italian study addressing the yield of sural nerve biopsy. During the years, we observed a progressive refinement of the indication of this procedure, which confirms its utility for interstitial neuropathies, particularly if non-systemic vasculitic neuropathy is suspected.",
keywords = "amyloidotic neuropathy, axonal neuropathies, demyelinating neuropathies, neuropathy, sural nerve biopsy, vasculitic neuropathy",
author = "Valeria Prada and Sara Massucco and Consuelo Venturi and Alessandro Geroldi and Emilia Bellone and Paola Mandich and Michele Minuto and Emanuela Varaldo and Giovanni Mancardi and Marina Grandis and Angelo Schenone",
year = "2019",
month = "11",
day = "22",
doi = "10.3389/fneur.2019.01218",
language = "English",
volume = "10",
journal = "Frontiers in Neurology",
issn = "1664-2295",
publisher = "Frontiers Research Foundation",

}

TY - JOUR

T1 - Diagnostic Value of Sural Nerve Biopsy

T2 - Retrospective Analysis of Clinical Cases From 1981 to 2017

AU - Prada, Valeria

AU - Massucco, Sara

AU - Venturi, Consuelo

AU - Geroldi, Alessandro

AU - Bellone, Emilia

AU - Mandich, Paola

AU - Minuto, Michele

AU - Varaldo, Emanuela

AU - Mancardi, Giovanni

AU - Grandis, Marina

AU - Schenone, Angelo

PY - 2019/11/22

Y1 - 2019/11/22

N2 - Nerve biopsy represents the conclusive step in the diagnostic work-up of peripheral neuropathies, and its diagnostic yield is still debated. The aim of this study is to consider the impact of nerve biopsy on reaching a useful diagnosis in different peripheral neuropathies and its changing over time. We retrospectively analyzed 1,179 sural nerve biopsies performed in the period 1981–2017 at Neurological Clinic of Policlinico San Martino (Genoa). We relied on medical records and collected both clinical and pathological data in a database. Biopsy provided univocal diagnoses in 53% of cases (with an increase over time), multiple diagnostic options in 14%, while diagnosis was undetermined in 33% (undetermined reports decreased during the years). In 57% of patients, the pre-biopsy suspicion was confirmed, while in 43% sural biopsy modified the clinical diagnosis. The highest yield was in axonal neuropathies (29% undetermined reports vs. 40% in demyelinating and 48% in mixed neuropathies). In 68% of patients with vasculitic neuropathy, this etiology was already suspected, whereas in 32% nerve biopsy modified the clinical diagnosis. During the years, the number of annually performed biopsies decreased significantly (p = 0.007), with an increase in the mean age of patients (p < 0.0001). The percentage of hereditary neuropathies had a significant decrease (p = 0.016), while the rate of vasculitic and chronic inflammatory neuropathies increased (p < 0.0001). This is the largest Italian study addressing the yield of sural nerve biopsy. During the years, we observed a progressive refinement of the indication of this procedure, which confirms its utility for interstitial neuropathies, particularly if non-systemic vasculitic neuropathy is suspected.

AB - Nerve biopsy represents the conclusive step in the diagnostic work-up of peripheral neuropathies, and its diagnostic yield is still debated. The aim of this study is to consider the impact of nerve biopsy on reaching a useful diagnosis in different peripheral neuropathies and its changing over time. We retrospectively analyzed 1,179 sural nerve biopsies performed in the period 1981–2017 at Neurological Clinic of Policlinico San Martino (Genoa). We relied on medical records and collected both clinical and pathological data in a database. Biopsy provided univocal diagnoses in 53% of cases (with an increase over time), multiple diagnostic options in 14%, while diagnosis was undetermined in 33% (undetermined reports decreased during the years). In 57% of patients, the pre-biopsy suspicion was confirmed, while in 43% sural biopsy modified the clinical diagnosis. The highest yield was in axonal neuropathies (29% undetermined reports vs. 40% in demyelinating and 48% in mixed neuropathies). In 68% of patients with vasculitic neuropathy, this etiology was already suspected, whereas in 32% nerve biopsy modified the clinical diagnosis. During the years, the number of annually performed biopsies decreased significantly (p = 0.007), with an increase in the mean age of patients (p < 0.0001). The percentage of hereditary neuropathies had a significant decrease (p = 0.016), while the rate of vasculitic and chronic inflammatory neuropathies increased (p < 0.0001). This is the largest Italian study addressing the yield of sural nerve biopsy. During the years, we observed a progressive refinement of the indication of this procedure, which confirms its utility for interstitial neuropathies, particularly if non-systemic vasculitic neuropathy is suspected.

KW - amyloidotic neuropathy

KW - axonal neuropathies

KW - demyelinating neuropathies

KW - neuropathy

KW - sural nerve biopsy

KW - vasculitic neuropathy

UR - http://www.scopus.com/inward/record.url?scp=85076709711&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85076709711&partnerID=8YFLogxK

U2 - 10.3389/fneur.2019.01218

DO - 10.3389/fneur.2019.01218

M3 - Article

AN - SCOPUS:85076709711

VL - 10

JO - Frontiers in Neurology

JF - Frontiers in Neurology

SN - 1664-2295

M1 - 1218

ER -